Invitae Corporation (NVTA)

0.5743 -0.0193 (-3.25%) At close: 03:59PM EST

Invitae Corporation

1400 16th Street
San Francisco, CA 94103
United States
415 374 7782
https://www.invitae.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full Time Employees: 1,700

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Randal W. Scott Ph.D.	Co-Founder & Chairman of the Board	50k	N/A	1958
Mr. Kenneth D. Knight	President, CEO & Director	1.4M	N/A	1961
Mr. Thomas R. Brida	General Counsel, Chief Compliance Officer & Secretary	776.72k	N/A	1971
Dr. Robert L. Nussbaum M.D.	Chief Medical Officer	751.95k	N/A	1950
Ms. Ana J. Schrank	Chief Accounting Officer & CFO	N/A	N/A	1966
Dr. David B. Sholehvar M.D.	Chief Operating Officer	N/A	N/A	1968
Ms. Hoki Luk	Head of Investor Relations and Capital Markets	N/A	N/A	1976
Ms. Shelly D. Guyer	Chief Sustainability Officer	430.44k	N/A	1960
Ms. Desarie French	Chief Talent Officer	N/A	N/A	N/A
Dr. W. Michael Korn M.D.	Chief Medical Officer	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.

Corporate Governance

Invitae Corporation’s ISS Governance QualityScore as of December 1, 2023 is 9. The pillar scores are Audit: 4; Board: 10; Shareholder Rights: 7; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.